Treatment Options for Squamous Cell Carcinoma Affecting Squamous Mucosa
The treatment of squamous cell carcinoma (SCC) affecting squamous mucosa should be based on a multidisciplinary approach with surgery or radiation therapy as primary modalities for early-stage disease, and combined modality treatment for advanced disease. 1
Diagnosis and Staging
Before initiating treatment, proper diagnosis and staging are essential:
- Clinical evaluation including complete physical examination with neck palpation and flexible head and neck fibreoptic endoscopy 1
- Pathological confirmation through biopsy is mandatory 1
- Contrast-enhanced CT scan and/or MRI to assess the primary tumor and regional lymph nodes 1
- Chest imaging (preferably CT) to assess for distant metastases 1
- FDG-PET/CT recommended for high-risk tumors or suspected recurrence 1
- HPV evaluation using p16 immunohistochemistry for oropharyngeal SCC 1
- PD-L1 expression evaluation for recurrent/metastatic disease 1
Treatment Algorithm Based on Disease Stage
1. Early Stage Disease (T1-2N0)
Primary options (similar locoregional control rates):
- External beam radiation therapy (EBRT)
- Brachytherapy for selected stage I oropharyngeal or oral cavity subsites
Key principle: Early disease should be treated with single-modality treatment (surgery OR radiation) whenever possible 1
2. Locally Advanced Disease (T3-4a or N+)
Primary options:
Surgery followed by adjuvant therapy 1, 2
- Surgical resection with appropriate margins
- Neck dissection for nodal disease
- Adjuvant radiotherapy or chemoradiotherapy based on pathologic risk factors
Concurrent chemoradiotherapy 1, 2
- Platinum-based regimens remain the standard
- Consider for organ preservation or unresectable disease
Induction chemotherapy followed by radiation or chemoradiation 1
- Option for larynx/hypopharynx cancer requiring total laryngectomy
3. Very Advanced Disease (T4b and/or unresectable lymph nodes)
Primary options:
- Concurrent chemoradiotherapy 1, 2
- Induction chemotherapy followed by radiation or chemoradiation for responders 1
- Palliative treatment: systemic therapy and/or palliative radiation 1
4. Recurrent or Metastatic Disease
Treatment options:
Special Considerations for Specific Anatomic Sites
Oral Cavity SCC
- Surgery is preferred for most oral cavity SCCs 1, 2
- Depth of invasion (DOI) is an important prognostic factor 1
- If DOI <5 mm and cT1N0, active surveillance of the neck is a valid option 1
- If DOI <10 mm, sentinel lymph node biopsy is a valid option 1
Oropharyngeal SCC
- HPV status is critical for prognosis and treatment planning 1
- p16-positive tumors have better prognosis and may be candidates for treatment de-escalation 1
- Treatment options include transoral surgery or radiation-based approaches 1, 2
Laryngeal SCC
- Early glottic cancers can be treated with laser cordectomy or radiation with excellent voice outcomes 1
- Advanced laryngeal cancer may be treated with larynx preservation protocols (chemoradiation) or total laryngectomy 1, 2
Penile Intraepithelial Neoplasia (PIN)
- Circumcision is an essential component of management for most cases 1
- Treatment options include surgical excision, Mohs micrographic surgery, or distal phalanx amputation 1
- Photodynamic therapy with MAL-PDT has shown efficacy in some cases 1
Adjuvant Therapy Indications
Adjuvant therapy should be considered for high-risk features:
- Positive margins (R1 resection) 1, 2
- Extracapsular nodal extension 1, 2
- Multiple positive lymph nodes 2
- Perineural invasion 2
- Lymphovascular invasion 1
Treatment Complications and Supportive Care
- Nutritional status assessment is crucial; enteral feeding may be necessary 1, 2
- Dental examination and rehabilitation before radiotherapy 2
- Speech and swallowing function evaluation 1
- Psychosocial support 1
Follow-up Recommendations
- Physical examination every 3-6 months for the first 2 years 2
- Imaging (CT or MRI) as clinically indicated 2
- Evaluation of thyroid function at 1,2, and 5 years if radiation was delivered to the neck 2
The treatment of squamous cell carcinoma affecting squamous mucosa requires a careful assessment of tumor and patient factors. Early-stage disease can often be treated with single-modality therapy, while advanced disease typically requires multimodality treatment. A multidisciplinary tumor board discussion is essential to determine the optimal treatment strategy for each patient.